Philip Morris International (PM) › Analysis

Philip Morris International (PM) stock analysis, November 3, 2026: Sector-led uptrend presses against its 52-week high

Published November 3, 2026 · updated 2026-11-06 · PM chart, levels and live analysis

Update, November 6, 2026

Since the November 3 report, PM fell 5.2% over five days to $197.88, underperforming the S&P 500's 2.7% drop and the Consumer Staples sector's 0.7% gain. The stock peaked at $211.28 on November 4 before retreating 6.3%, pressured by a broad market pullback and profit-taking after a strong run. Sector peers like Altria rallied on earnings, but PM's relative weakness against XLP (-4.5% over 50 days) suggests stock-specific consolidation rather than sector contagion.

The picture holds: the daily trend still aligns with the weekly uptrend, and price remains above its 40-week average and the 50-day SMA at $195.52. The key support has not moved — a daily close below $195.52 would crack the structure, with the trend ending below $190.66 (a weekly close below that swing zone would change the picture). The breakout level remains a daily close above $200.0 on above-average volume, with the 52-week high at $211.28 as the target. However, conviction has dropped from high to medium (2 of 4 points) because the 5-day underperformance versus XLP contradicts the bullish trend. The stop at $194.03 (50-day SMA minus a quarter of ATR) offers a 1.9 reward-to-risk to the high, below the 3-to-1 threshold. The Motley Fool highlighted PM's 3.2% dividend yield and pricing power, supporting the long-term thesis, but near-term momentum has stalled.

Philip Morris International (PM) trades at $208.21, 0.3% below its October 30 closing high of $208.79, and the evidence leans positive with high conviction for the next two to six weeks. The stock has gained 11.3% in a month after a third quarter that beat estimates but came with a warning on conflict-driven costs. Much of the recent move came from the staples sector rather than PM alone. The next test is a volume-backed close above the high.

Why it matters

PM reported third-quarter results on October 21, 2026. Reuters reported a beat on smoke-free demand, alongside a warning that conflicts in the Middle East and Ukraine are raising costs. Full-year adjusted earnings per share are now expected in the middle to lower half of the $8.29 to $8.44 guidance range. Organic net revenue grew 7%, and The Motley Fool noted PM is cutting the price per ZYN pouch by 25% by adding five pouches to each can. The 10-Q shows the same split: revenue of $11.44 billion, up 5%, and net income of $3.31 billion, down 5%. Sales are growing while costs and price investment squeeze earnings.

The market did not treat that as a problem. Benzinga had options pricing an earnings move of about 4.18%. Since then the stock is up 11.3% over a month, 25.4% over six months and 30.0% year to date, so buyers looked through the guidance trim. The news does not explain the late-October push to a new high. The timing coincides with Altria's results: Yahoo! Finance reported Altria shares rose 5.2% on October 29 after it raised its full-year guidance. That is a plausible read-across for tobacco, but it is not proof.

The five-day numbers show where the move came from. PM gained 2.9% while the S&P 500 (SPY) fell 2.1% and the staples ETF (XLP) rose 2.4%. PM beat its sector by only 0.5 points, so this has been mostly a sector move, with defensives bid as the broad market slipped. Today the pattern held: XLP fell 1.7%, SPY rose 0.2%, and PM was flat at -0.04%.

The debate is about durability. The bullish case, The Motley Fool argues, is a 3.2% yield, annual dividend increases since 2008 (the latest 8.8%), and organic gross profit from combustibles up 7.4% on pricing power. The cautious case comes from Morningstar: smoke-free products were 41.5% of 2025 revenue against a target of two-thirds by 2030, so the transition is far from finished. The ZYN price cut is where that tension shows, trading price for volume in the growth product. On valuation, the 15 analysts rate the stock a buy with a mean price target of $211.47, only 1.5% above the price. Targets run from $175 to $240. The stock already sits near consensus, so further gains need estimates or targets to rise.

What the evidence says

The long-term thesis is intact. Price is above its 40-week average, the 50-day average ($194.88) sits above the 200-day ($182.23), and the stock is 44% above its 52-week low of $144.60. It is in an advancing phase and pausing just under its high, not building a top.

For the next two to six weeks the balance of evidence leans positive, and conviction is high at 3 of 4. The daily trend runs with the weekly uptrend. PM leads the S&P 500 by 8.7% over 50 days and leads XLP by 1.5%. The strongest case against is that the lead over staples is thin, 1.5 points over 50 days and 0.5 over five, so PM is largely riding its sector. Volume is also 59.8% below its 20-day average, and RSI at 53.7 shows no momentum surge. If staples reverse, PM would likely follow. This does not tip the balance, because the stock held flat on a day XLP fell 1.7%, but it is why conviction is not higher.

Levels that matter

The structure holds above $200, a round number and the first level where buyers would be tested. A close below it would be the first crack. The trend ends below $194.88, the 50-day average, which sits just above a swing zone at $195.79 and is the line the weekly trend has leaned on. Below that, swing support is at $191.26 and $184.76.

The breakout level is a daily close above $208.79, the 52-week high, on volume above its 20-day average. From there the math gives a stop at $198.57, which is $200 minus a quarter of the 14-day ATR ($5.71). The first target is $225, a round number, at 1.6 to 1. The second is $250, at 4.0 to 1. The 3-to-1 threshold is therefore met only at the second target, not the first.

What would change the picture

A weekly close below $194.88, the 50-day average, would change the picture. The non-price fact that would most likely cause it is another cut to the full-year earnings outlook, moving guidance below the $8.29 to $8.44 range. That would show conflict costs and the ZYN price investment outweighing pricing power.

What to watch

Get a message when the PM picture changes — the agent team watches the levels and the news for you.Create a free account

More PM analyses

Research & education, not advice. MarketCrew is AI-powered and can make mistakes.